{"id":61432,"date":"2024-02-28T07:40:41","date_gmt":"2024-02-28T07:40:41","guid":{"rendered":"https:\/\/medsname.com\/mefque\/"},"modified":"2026-04-30T10:23:35","modified_gmt":"2026-04-30T10:23:35","slug":"mefque","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/mefque\/","title":{"rendered":"Mefque"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8d6;border-left:4px solid #f5c518;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">R\u0103spuns rapid<\/h3>\n<p><strong>Mefque<\/strong> con\u021bine <strong>mefloquine 250 mg<\/strong> (Cipla). Este o op\u021biune de chimioprofilaxie s\u0103pt\u0103m\u00e2nal\u0103 pentru <strong>malaria rezistent\u0103 la clorochin\u0103<\/strong> \u00een Africa subsaharian\u0103, India, Asia de Sud-Est (cu excep\u021bia frontierelor Thailanda-Cambodgia \/ Thailanda-Myanmar) \u0219i Amazonia. Doza pentru adul\u021bi: 250 mg o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103, \u00eenceput\u0103 <strong>cu 2\u20133 s\u0103pt\u0103m\u00e2ni \u00eenainte de c\u0103l\u0103torie<\/strong> (pentru a identifica intoleran\u021ba \u0219i a atinge starea de echilibru), continuat \u00een timpul c\u0103l\u0103toriei \u0219i continuat <strong>4 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eentoarcere<\/strong>. Se administreaz\u0103 cu o mas\u0103 complet\u0103 \u0219i ap\u0103. <strong>Doza de test obligatorie \u00eenainte de c\u0103l\u0103torie cu 3 s\u0103pt\u0103m\u00e2ni \u00eenainte de plecare<\/strong> \u2014 dac\u0103 apar efecte adverse neuropsihiatrice, trece\u021bi la doxiciclin\u0103 sau atovaquon-proguanil \u00eenainte de zbor. Contraindicat la pacien\u021bii cu depresie actual\u0103 sau trecut\u0103, tulburare de anxietate generalizat\u0103, psihoz\u0103, schizofrenie, tulburare bipolar\u0103, tulbur\u0103ri de convulsii sau anomalie semnificativ\u0103 de conducere cardiac\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f4f4;border:1px solid #e0e0e0;border-radius:6px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.5;\"><strong>\ud83c\udfed Produc\u0103tor certificat WHO-GMP<\/strong> &nbsp;\u00b7&nbsp; <strong>\ud83d\udce6 Ambalaj discret<\/strong> &nbsp;\u00b7&nbsp; <strong>\ud83c\udf0d Livrare \u00een toat\u0103 lumea<\/strong> &nbsp;\u00b7&nbsp; <strong>\u2b50 <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">Peste 1.400 de recenzii ale clien\u021bilor<\/a><\/strong><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:13px;color:#555;margin:10px 0 18px;\">\ud83d\udee1\ufe0f Fiecare comand\u0103 este acoperit\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days we ship a free replacement on EMS or ITPS courier.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Mefque este procurat de la un produc\u0103tor certificat WHO-GMP \u0219i expediat \u00een toat\u0103 lumea \u00een ambalaje discrete. Fiecare comand\u0103 este sus\u021binut\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a> \u0219i sprijinit\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">Peste 1.400 de recenzii ale clien\u021bilor<\/a>. Livrare worldwide f\u0103r\u0103 documenta\u021bie medical\u0103.<\/p>\n<h2>Despre Mefque<\/h2>\n<p>Mefque este un comprimat de 250 mg de meflochin\u0103 hidroclorur\u0103 fabricat de Cipla \u00een condi\u021bii certificate WHO-GMP. Meflochina a fost dezvoltat\u0103 de US Walter Reed Army Institute of Research \u00een anii 1970 \u0219i r\u0103m\u00e2ne una dintre cele trei op\u021biuni moderne (al\u0103turi de doxiciclin\u0103 \u0219i atovaquon-proguanil) pentru profilaxia \u00een zonele rezistente la clorochin\u0103. Semivia\u021ba sa lung\u0103 permite administrarea o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103 \u2014 convenabil pentru c\u0103l\u0103torii lungi.<\/p>\n<h2>Cum func\u021bioneaz\u0103 meflochina<\/h2>\n<p>Meflochina este un antimalaric din clasa 4-quinolinemethanol. La fel ca clorochina, interfereaz\u0103 cu detoxifierea hemului parazitului \u00een vacuola alimentar\u0103, dar este activ\u0103 \u00eempotriva multor tulpini rezistente la clorochin\u0103 deoarece nu depinde de acela\u0219i mecanism de transport al parazitului. Are \u0219i activitate \u00eempotriva stadiului sanguin al P. falciparum, P. vivax, P. ovale \u0219i P. malariae. Meflochina are penetrare substan\u021bial\u0103 \u00een SNC \u2014 dezirabil\u0103 pentru eficacitatea parasitologic\u0103, dar sursa profilului s\u0103u de efecte adverse neuropsihiatrice.<\/p>\n<p>Semivia\u021ba este de ~ 2\u20133 s\u0103pt\u0103m\u00e2ni. Administrarea o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103 atinge starea de echilibru p\u00e2n\u0103 \u00een s\u0103pt\u0103m\u00e2nile 7\u20139; de aceea majoritatea autorit\u0103\u021bilor recomand\u0103 \u00eenceperea cu 2\u20133 s\u0103pt\u0103m\u00e2ni \u00eenainte de c\u0103l\u0103torie.<\/p>\n<h2>Indica\u021bii \u0219i dozaj<\/h2>\n<div style=\"overflow-x:auto;margin:18px 0;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:14px;\">\n<thead>\n<tr>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Indica\u021bie<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Doza<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Program<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Chimioprofilaxie, adul\u021bi<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">250 mg o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">\u00cencepe\u021bi cu 2\u20133 s\u0103pt\u0103m\u00e2ni \u00eenainte de a intra \u00een zona de malarie; continua\u021bi s\u0103pt\u0103m\u00e2nal \u00een timpul expunerii; continua\u021bi 4 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eentoarcere.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Chimioprofilaxie pediatric\u0103 (\u2265 5 kg)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">5 mg\/kg o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103 (maxim 250 mg)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Acela\u0219i program de \u00eencepere\/continuare\/oprire. Jum\u0103tate de tablet\u0103 pentru copiii mai mici \u2014 doza exact\u0103 \u00een mg\/kg conteaz\u0103.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Malarie acut\u0103 necomplicat\u0103 cu P. falciparum rezistent la clorochin\u0103, adul\u021bi<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">750 mg doz\u0103 unic\u0103, urmat\u0103 de 500 mg dup\u0103 6\u201312 ore (total 1250 mg)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Dozele terapeutice provoac\u0103 semnificativ mai multe efecte adverse dec\u00e2t cele profilactice. Preferin\u021ba actual\u0103 a WHO este terapia combinat\u0103 cu artemisinin\u0103 acolo unde este disponibil\u0103.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Tratament de urgen\u021b\u0103 pentru malarie presupus\u0103<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">750 mg + 500 mg conform schemei de mai sus<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Pentru c\u0103l\u0103torii \u00een zone f\u0103r\u0103 acces rapid la \u00eengrijiri medicale care dezvolt\u0103 o afec\u021biune febril\u0103 compatibil\u0103 cu malaria. Nu \u00eenlocuie\u0219te evaluarea medical\u0103.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.6;\"><strong>Avertisment neuropsihiatric \u00een caset\u0103 ro\u0219ie \u2014 citi\u021bi \u00eenainte de cump\u0103rare.<\/strong> Meflochina este asociat\u0103 cu anxietate, vise vii, co\u0219maruri, insomnie, modific\u0103ri de stare, depresie, g\u00e2nduri suicidare, paranoia, halucina\u021bii \u0219i rareori convulsii. Majoritatea reac\u021biilor apar \u00een primele 3 doze. Unii pacien\u021bi descriu simptome persistente (\u201csindrom post-meflochin\u0103\u201d) dup\u0103 \u00eentreruperea medicamentului. <strong>Contraindica\u021bii:<\/strong> depresie curent\u0103 sau trecut\u0103, tulburare de anxietate generalizat\u0103, psihoz\u0103, schizofrenie, tulburare bipolar\u0103, tulburare de convulsii, anomalie sever\u0103 de conduc\u021bie cardiac\u0103, traumatism cranian recent, istoric de boal\u0103 psihiatric\u0103 sever\u0103 \u00een familie apropiat\u0103. Efectua\u021bi \u00eentotdeauna un <strong>test doz\u0103 de 3 s\u0103pt\u0103m\u00e2ni \u00eenainte de c\u0103l\u0103torie<\/strong>: dac\u0103 apar anxietate, disforie, vise vii sau tulbur\u0103ri de somn, trece\u021bi la doxiciclin\u0103 sau atovaquon-proguanil \u00eenainte de zbor.<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.6;\"><strong>Not\u0103 cardiac\u0103.<\/strong> Mefloquina prelunge\u0219te intervalul PR \u0219i prelunge\u0219te moderat QTc. Evita\u021bi combina\u021bia cu alte medicamente care prelungesc QT (azitromicin\u0103, ondansetron, fluoroquinolone, antipsihotice, SSRI \/ TCA la doze mari). Evita\u021bi la pacien\u021bii cu bradicardie, bloc AV sau dependen\u021b\u0103 de stimulator cardiac f\u0103r\u0103 consult cardiologic.<\/div>\n<h2>Efecte secundare<\/h2>\n<ul>\n<li><strong>Frecvente (10\u201325%):<\/strong> gre\u021buri, ame\u021beli, vise vii, insomnie u\u0219oar\u0103, cefalee.<\/li>\n<li><strong>Mai pu\u021bin frecvente (5\u201310%):<\/strong> anxietate, modific\u0103ri de stare, oboseal\u0103, tulbur\u0103ri gastrointestinale, pierdere u\u0219oar\u0103 de p\u0103r, fotosensibilitate.<\/li>\n<li><strong>Pu\u021bin frecvente, dar importante:<\/strong> depresie (uneori sever\u0103), g\u00e2nduri suicidare, paranoia, halucina\u021bii, atacuri de panic\u0103, simptome disociative \u2014 acestea persist\u0103 adesea dup\u0103 \u00eentreruperea medicamentului.<\/li>\n<li><strong>Rare dar grave:<\/strong> convulsii, encefalopatie, bloc AV, bradicardie, reac\u021bii cutanate severe (Stevens-Johnson, necroliz\u0103 epidermic\u0103 toxic\u0103), agranulocitoz\u0103, hepatotoxicitate sever\u0103, tulbur\u0103ri vestibulare severe.<\/li>\n<li><strong>Sarcina:<\/strong> poate fi utilizat\u0103 \u00een trimestrul al doilea \u0219i al treilea pentru profilaxie \u0219i tratament; datele pentru primul trimestru sunt \u00eencurajatoare dar limitate. Utiliza\u021bi cea mai mic\u0103 doz\u0103 eficient\u0103.<\/li>\n<\/ul>\n<h2>Interac\u021biuni medicamentoase<\/h2>\n<div style=\"overflow-x:auto;margin:18px 0;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:14px;\">\n<thead>\n<tr>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Interac\u021biune<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Efect<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Management<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Chinin\u0103 \/ clorochin\u0103 \/ hidroxiclorochin\u0103<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Cardiotoxicitate aditiv\u0103 + sc\u0103derea pragului convulsiv<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Evita\u021bi combina\u021bia \u2014 utiliza\u021bi un singur antimalaric.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Anticonvulsante (carbamazepin\u0103, fenitoin\u0103, valproat)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Mefloquina poate sc\u0103dea pragul convulsiilor \u0219i reduce nivelul anticonvulsivelor prin intermediul CYP3A4<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Mefloquina este contraindicat\u0103 \u00een tulbur\u0103rile convulsive.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Beta-blocante \/ blocante ale canalelor de calciu \/ digoxin<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Bradicardie aditiv\u0103 \/ bloc AV<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Consult cardiologic; lua\u021bi \u00een considerare un alt antimalaric.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Halofantrin\u0103<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Prelungire sever\u0103 a intervalului QTc, raportate aritmii fatale<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Contraindica\u021bie absolut\u0103.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Ketoconazol \/ inhibitori puternici ai CYP3A4<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Cre\u0219te nivelul mefloquinei \u0219i efectul asupra QTc<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Evita\u021bi combina\u021bia.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Rifampicin\u0103 \/ rifabutin\u0103 \/ inductori puternici ai CYP3A4<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Sc\u0103derea nivelului mefloquinei \u2014 risc de e\u0219ec al profilaxiei<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Evita\u021bi combina\u021bia; alege\u021bi un alt antimalaric.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Medicamente care prelungesc QTc (azitromicin\u0103, ondansetron, antipsihotice, SSRI \/ TCA)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Prelungire aditiv\u0103 a intervalului QTc<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Evita\u021bi la pacien\u021bii cu tulbur\u0103ri electrolitice sau QT prelungit preexistent.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Vaccin oral viu \u00eempotriva tifosului (Ty21a)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Mefloquina inactiveaz\u0103 vaccinul viu<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Finaliza\u021bi seria de vaccinare cu cel pu\u021bin 12 ore \u00eenainte de administrarea mefloquinei.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Contraindica\u021bii \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Contraindica\u021bii absolute:<\/strong> hipersensibilitate la meflochin\u0103 sau antimalarice \u00eenrudite din clasa chinolinei; depresie major\u0103 actual\u0103 sau trecut\u0103, tulburare de anxietate generalizat\u0103, psihoz\u0103, schizofrenie, tulburare bipolar\u0103, tulburare convulsiv\u0103; anomalie sever\u0103 de conduc\u021bie cardiac\u0103 (bloc AV de grad \u00eenalt, bradicardie sever\u0103); administrare concomitent\u0103 cu halofantrin\u0103.<\/li>\n<li><strong>Precau\u021bie mare:<\/strong> istoric de depresie\/anxietate inactiv \u00een prezent, traumatism craniocerebral recent, insuficien\u021b\u0103 hepatic\u0103 sau renal\u0103 sever\u0103, tulbur\u0103ri vestibulare.<\/li>\n<li><strong>Sarcina:<\/strong> compatibil dup\u0103 primul trimestru; date limitate pentru primul trimestru, dar \u00eencurajatoare. Malaria falciparum netratat\u0103 \u00een sarcin\u0103 este mult mai periculoas\u0103.<\/li>\n<li><strong>Al\u0103ptarea:<\/strong> compatibil - secretat \u00een laptele matern \u00een cantit\u0103\u021bi mici insuficiente pentru profilaxia infantil\u0103.<\/li>\n<\/ul>\n<h2>Depozitare<\/h2>\n<p>Se p\u0103streaz\u0103 la temperaturi sub 30 \u00b0C, \u00eentr-un loc uscat, \u00een ambalajul original. Se \u021bine la distan\u021b\u0103 de copii.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>De ce s\u0103 \u00eencepe\u021bi Mefque cu 2-3 s\u0103pt\u0103m\u00e2ni \u00eenainte de c\u0103l\u0103torie?<\/h3>\n<p>Dou\u0103 motive: pentru a detecta precoce intoleran\u021ba neuropsihiatric\u0103 (pentru a putea schimba antimalaricul \u00eenainte de zbor) \u0219i pentru a permite nivelurilor sanguine s\u0103 creasc\u0103 spre un echilibru stabil. Unele autorit\u0103\u021bi recomand\u0103 3 s\u0103pt\u0103m\u00e2ni; minimul este de 2 s\u0103pt\u0103m\u00e2ni.<\/p>\n<h3>Cine NU ar trebui s\u0103 ia meflochin\u0103?<\/h3>\n<p>Oricine are depresie actual\u0103 sau trecut\u0103, tulburare de anxietate generalizat\u0103, psihoz\u0103, schizofrenie, tulburare bipolar\u0103, tulburare convulsiv\u0103, anomalie sever\u0103 de conduc\u021bie cardiac\u0103, traumatism craniocerebral recent sau istoric familial puternic de boli psihiatrice severe. Ace\u0219ti pacien\u021bi ar trebui s\u0103 aleag\u0103 doxiciclin\u0103 (Cendox) sau atovaquon-proguanil \u00een schimb.<\/p>\n<h3>Ce fac dac\u0103 am vise vii?<\/h3>\n<p>Visurile vii \u00een sine sunt frecvente (15\u201320 %) \u0219i adesea tolerabile. Co\u0219marurile severe, tulbur\u0103rile de somn, anxietatea sau schimb\u0103rile de stare sunt motive pentru a schimba antimalaricul \u2014 face\u021bi acest lucru \u00ceNAINTE de zbor, c\u00e2t \u00eenc\u0103 ave\u021bi alternative disponibile.<\/p>\n<h3>Este \u00eenc\u0103 meflochina utilizat\u0103 pe scar\u0103 larg\u0103?<\/h3>\n<p>Da, pentru profilaxie \u00een timpul sarcinii (unde atovaquon-proguanil este mai pu\u021bin stabilit \u0219i doxiciclina este contraindicat\u0103) \u0219i pentru c\u0103l\u0103torii care doresc dozare o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103 \u00een c\u0103l\u0103torii lungi. Multe clinici de medicin\u0103 de c\u0103l\u0103torie prefer\u0103 acum atovaquon-proguanil atunci c\u00e2nd costul \u0219i profilul efectelor secundare sunt preocup\u0103ri; meflochina r\u0103m\u00e2ne o alegere valid\u0103 dup\u0103 o doz\u0103 de test atent\u0103.<\/p>\n<h3>Pot s\u0103 iau Mefque \u0219i s\u0103 consum alcool?<\/h3>\n<p>Consumul moderat de alcool este acceptabil. Consumul excesiv amplific\u0103 efectele asupra SNC (ame\u021beli, anxietate, tulbur\u0103ri de stare) \u0219i ar trebui evitat.<\/p>\n<h3>Cauzeaz\u0103 meflochina leziuni cerebrale permanente?<\/h3>\n<p>Majoritatea efectelor secundare se rezolv\u0103 dup\u0103 \u00eentreruperea medicamentului. O minoritate de pacien\u021bi descriu simptome persistente (\u201csindrom post-meflochin\u0103\u201d). Mecanismul este neclar \u0219i prevalen\u021ba este dezb\u0103tut\u0103. Doza de test de 3 s\u0103pt\u0103m\u00e2ni \u00eenainte de c\u0103l\u0103torie exist\u0103 special pentru a identifica pacien\u021bii care nu ar trebui s\u0103 continue medicamentul \u00eenainte de apari\u021bia efectelor persistente.<\/p>\n<h3>Pot s\u0103 iau Mefque \u00een sarcin\u0103?<\/h3>\n<p>Da \u2014 meflochina este unul dintre antimalaricele preferate pentru profilaxie \u00een sarcin\u0103 dup\u0103 primul trimestru. Datele pentru primul trimestru sunt lini\u0219titoare, dar limitate. Malaria neprelucrat\u0103 cu Plasmodium falciparum \u00een sarcin\u0103 este mult mai periculoas\u0103 dec\u00e2t meflochina.<\/p>\n<h3>Ce se \u00eent\u00e2mpl\u0103 dac\u0103 uit o doz\u0103 s\u0103pt\u0103m\u00e2nal\u0103?<\/h3>\n<p>Lua\u021bi-o c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi. Dac\u0103 a trecut mai mult de 3 zile, lua\u021bi-o \u0219i relua\u021bi programul original \u00een ziua s\u0103pt\u0103m\u00e2nii s\u0103pt\u0103m\u00e2na urm\u0103toare. Nu dubla\u021bi doza.<\/p>\n<h3>De ce difer\u0103 doza pentru tratament fa\u021b\u0103 de profilaxie?<\/h3>\n<p>Profilaxia previne stabilirea infec\u021biei parazitare \u2014 nivelurile modeste constante din s\u00e2nge sunt suficiente. Tratamentul trebuie s\u0103 elimine o \u00eenc\u0103rc\u0103tur\u0103 parazitar\u0103 stabilit\u0103 \u2014 sunt necesare doze de v\u00e2rf mult mai mari (1 250 mg total \u00een 12 ore), cu efecte secundare propor\u021bional mai mari.<\/p>\n<h3>Ar trebui s\u0103 iau Mefque cu m\u00e2ncare?<\/h3>\n<p>Da \u2014 administrarea cu o mas\u0103 complet\u0103 reduce substan\u021bial grea\u021ba \u0219i \u00eembun\u0103t\u0103\u021be\u0219te absorb\u021bia. Evita\u021bi s\u0103 lua\u021bi pe stomacul gol.<\/p>\n<h3>Pot lua mefloquin\u0103 pentru tratamentul malariei dac\u0103 m\u0103 \u00eemboln\u0103vesc \u00een timpul c\u0103l\u0103toriei?<\/h3>\n<p>Auto-tratamentul malariei presumptive este rezervat c\u0103l\u0103torilor din zone \u00eendep\u0103rtate f\u0103r\u0103 acces la \u00eengrijiri medicale. Dac\u0103 pute\u021bi ajunge la un medic, face\u021bi asta \u2014 terapia modern\u0103 cu combina\u021bii de artemisin\u0103 este mai sigur\u0103 \u0219i mai eficient\u0103 pentru infec\u021bia confirmat\u0103. Dozele de tratament cu mefloquin\u0103 provoac\u0103 semnificativ mai multe efecte secundare dec\u00e2t dozele profilactice.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte Comprimate pentru Malarie<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cendox\/\"><strong>Cendox 100 mg<\/strong><\/a> \u2014 Doxiciclin\u0103 \u2014 alternativ\u0103 zilnic\u0103 pentru c\u0103l\u0103torii cu contraindica\u021bii neuropsihiatrice la mefloquin\u0103<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lariago\/\"><strong>Lariago 250 mg<\/strong><\/a> \u2014 Clorochin\u0103 \u2014 doar pentru pu\u021binele destina\u021bii r\u0103mase sensibile la clorochin\u0103<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hcqs\/\"><strong>HCQS 200\/400 mg<\/strong><\/a> \u2014 Hidroxiclorochin\u0103 \u2014 aminochinolin\u0103 alternativ\u0103 cu utilizare \u00een afec\u021biuni autoimune<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/primaquine\/\"><strong>Primachin\u0103 15 mg<\/strong><\/a> \u2014 Tratament radical pentru malaria recidivant\u0103 P. vivax \/ P. ovale \u2014 este necesar test G6PD<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/quinin-300\/\"><strong>Chinin\u0103 300 mg<\/strong><\/a> \u2014 Chinin\u0103 \u2014 tratament de linia a doua pentru P. falciparum rezistent la clorochin\u0103<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0;font-size:13px;line-height:1.6;\"><strong>Not\u0103 medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 con\u021bine doar informa\u021bii generale \u0219i nu \u00eenlocuie\u0219te sfaturile de medicin\u0103 de c\u0103l\u0103torie sau tratamentul sub supraveghere medical\u0103. Modelele de rezisten\u021b\u0103 la medicamente specifice destina\u021biei se schimb\u0103 \u2014 confirma\u021bi alegerea profilaxiei conform <a href=\"https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/preparing\/malaria\" rel=\"nofollow noopener\" target=\"_blank\">CDC Yellow Book<\/a> sau <a href=\"https:\/\/www.fitfortravel.nhs.uk\/destinations\" rel=\"nofollow noopener\" target=\"_blank\">fitfortravel.nhs.uk<\/a> ghidurilor actuale \u00eenainte de c\u0103l\u0103torie. Orice boal\u0103 febril\u0103 \u00een decurs de 1 an de la c\u0103l\u0103toria \u00eentr-o zon\u0103 endemic\u0103 pentru malarie necesit\u0103 examinare urgent\u0103 cu frotiu sanguin gros \u0219i sub\u021bire. Malaria sever\u0103 (tulbur\u0103ri de con\u0219tiin\u021b\u0103, icter, hipoglicemie, detres\u0103 respiratorie) reprezint\u0103 o urgen\u021b\u0103 medical\u0103.<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2705 Previne malaria<br \/>\n\u2705 Effective against chloroquine-resistant malaria<br \/>\n\u2705 Convenient once-weekly dosage<br \/>\n\u2705 Well-tolerated by most individuals<br \/>\n\u2705 Potrivit pentru utilizare pe termen lung<\/p>\n<p>Mefque contains Mefloquine.<\/p>","protected":false},"featured_media":0,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3580,3448],"product_tag":[5030,5031],"class_list":{"0":"post-61432","1":"product","2":"type-product","3":"status-publish","5":"product_cat-category-overview","6":"product_cat-malaria-tablets","7":"product_cat-travel-health-category-overview","8":"product_tag-mefloquine","9":"product_tag-mefque","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/61432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=61432"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=61432"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=61432"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=61432"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=61432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}